Home  |  Contact

Cellosaurus Kasumi-3 (CVCL_0612)

[Text version]

Cell line name Kasumi-3
Synonyms KASUMI-3; Kasumi 3; Kasumi3; KASUMI3
Accession CVCL_0612
Resource Identification Initiative To cite this cell line use: Kasumi-3 (RRID:CVCL_0612)
Comments Part of: MD Anderson Cell Lines Project.
Population: Japanese.
Doubling time: 55-60 hours (PubMed=8613429); ~3-4 days (DSMZ).
Omics: Protein expression by reverse-phase protein arrays.
Omics: SNP array analysis.
Omics: Transcriptome analysis.
Derived from sampling site: Bone marrow myeloblasts.
Disease Adult acute myeloid leukemia with minimal differentiation (NCIt: C8303)
Acute myeloid leukemia with minimal differentiation (ORDO: Orphanet_98832)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 57Y
Category Cancer cell line
STR profile Source(s): ATCC; DSMZ; JCRB

Markers:
AmelogeninX,Y
CSF1PO11
D5S81812
D7S82010,11
D13S31711,12
D16S5399,11 (ATCC; JCRB)
11 (DSMZ)
TH016,9,11 (ATCC)
6,9 (DSMZ; JCRB)
TPOX8
vWA16,18

Run an STR similarity search on this cell line
Web pages http://www.infarktforschung.de/macrophages_cell_lines.html
http://tcpaportal.org/mclp/
Publications

PubMed=8613429; DOI=10.1111/j.1349-7006.1996.tb00216.x
Asou H., Suzukawa K., Kita K., Nakase K., Ueda H., Morishita K., Kamada N.
Establishment of an undifferentiated leukemia cell line (Kasumi-3) with t(3;7)(q27;q22) and activation of the EVI1 gene.
Jpn. J. Cancer Res. 87:269-274(1996)

DOI=10.1016/B978-0-12-221970-2.50457-5
Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001)

PubMed=14504097; DOI=10.1182/blood-2003-02-0418
Taketani T., Taki T., Sugita K., Furuichi Y., Ishii E., Hanada R., Tsuchida M., Sugita K., Ida K., Hayashi Y.
FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy.
Blood 103:1085-1088(2004)

PubMed=23955599; DOI=10.1038/ng.2731
Kon A., Shih L.-Y., Minamino M., Sanada M., Shiraishi Y., Nagata Y., Yoshida K., Okuno Y., Bando M., Nakato R., Ishikawa S., Sato-Otsubo A., Nagae G., Nishimoto A., Haferlach C., Nowak D., Sato Y., Alpermann T., Nagasaki M., Shimamura T., Tanaka H., Chiba K., Yamamoto R., Yamaguchi T., Otsu M., Obara N., Sakata-Yanagimoto M., Nakamaki T., Ishiyama K., Nolte F., Hofmann W.K., Miyawaki S., Chiba S., Mori H., Nakauchi H., Koeffler H.P., Aburatani H., Haferlach T., Shirahige K., Miyano S., Ogawa S.
Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.
Nat. Genet. 45:1232-1237(2013)

PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005
Li J., Zhao W., Akbani R., Liu W., Ju Z., Ling S., Vellano C.P., Roebuck P., Yu Q., Eterovic A.K., Byers L.A., Davies M.A., Deng W., Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D., Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y., Mills G.B., Liang H.
Characterization of human cancer cell lines by reverse-phase protein arrays.
Cancer Cell 31:225-239(2017)

PubMed=32180206; DOI=10.1007/s13577-020-00347-5
Kasai F., Asou H., Ozawa M., Kobayashi K., Kuramitsu H., Satoh M., Kohara A., Kaneko Y., Kawamura M.
Kasumi leukemia cell lines: characterization of tumor genomes with ethnic origin and scales of genomic alterations.
Hum. Cell 33:0-0(2020)

Cross-references
Cell line collections ATCC; CRL-2725
DSMZ; ACC-714
JCRB; JCRB1004
JCRB; NIHS0236 - Discontinued
Ontologies CLO; CLO_0007070
Biological sample resources BioSample; SAMN01821573
BioSample; SAMN01821689
BioSample; SAMN03471777
BioSample; SAMN03472527
BioSample; SAMN03473397
Chemistry resources GDSC; 1327776
PharmacoDB; Kasumi3_735_2019
Gene expression databases GEO; GSM1374591
GEO; GSM4254131
Other Wikidata; Q54899520
Polymorphism and mutation databases Cosmic; 787442
Cosmic; 975259
Cosmic; 996310
Cosmic; 1037659
Cosmic; 2089647
Entry history
Entry creation04-Apr-2012
Last entry update02-Jul-2020
Version number20